U.S. VACCINE MARKET ANALYSIS
U.S. Vaccine Market: Restraint
High cost of refrigeration of vaccines
High cost of refrigeration of vaccines is expected to hinder the growth of the market. For vaccines, refrigeration is mandatory to prevent alteration of their chemical structure mainly due to contact with water and humidity resulting in ineffective medications. Maintaining this cold chain from production until they are used in treatment is a costly process accounting for about 80% of the price of vaccinations. For instance, The vaccine, developed by Pfizer and the German firm BioNTech, seems to provide 90% immunity according to early data released. The vaccine has to be stored at -70 degrees Celsius. freezers don’t get that cold, making distribution of this vaccine refrigeration which cost US$10,000 to US$15,000 each.
Market Players are taking initiative to launch cost-effective products.
U.S. Vaccine Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request DiscountPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :